• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologists consensus statement].

作者信息

Pruszczyk Piotr, Stępińska Janina, Banasiak Waldemar, Członkowska Anna, Opolski Grzegorz, Niewada Maciej, Ponikowski Piotr, Tendera Michał, Windyga Jerzy

机构信息

Klinika Chorób Wewnętrznych i Kardiologii, Warszawski Uniwersytet Medyczny, Warszawa.

出版信息

Kardiol Pol. 2012;70(9):979-88.

PMID:22993019
Abstract
摘要

相似文献

1
[New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologists consensus statement].[新型口服抗凝药用于预防心房颤动患者的栓塞并发症。波兰心脏病学会、波兰神经病学学会以及波兰血液学家和输血学家学会止血工作组共识声明]
Kardiol Pol. 2012;70(9):979-88.
2
A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation.心房颤动治疗中新型抗凝剂选择的指导路径。
Crit Pathw Cardiol. 2012 Jun;11(2):55-61. doi: 10.1097/HPC.0b013e31825298ef.
3
[Preventive treatment of systemic embolic complications of atrial fibrillation].[心房颤动系统性栓塞并发症的预防性治疗]
Ann Cardiol Angeiol (Paris). 1992 Mar;41(3):163-9.
4
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.利伐沙班每日一次、口服、直接 Xa 因子抑制与维生素 K 拮抗剂用于预防卒中和心房颤动的栓塞试验：ROCKET AF 研究的原理和设计。
Am Heart J. 2010 Mar;159(3):340-347.e1. doi: 10.1016/j.ahj.2009.11.025.
5
Stroke prevention in atrial fibrillation: current status and near-future directions.心房颤动的卒中预防：现状与近期方向。
Am J Med. 2011 Sep;124(9):793-9. doi: 10.1016/j.amjmed.2011.03.013.
6
Atrial fibrillation and embolic complications.
East Afr Med J. 1997 Jan;74(1):3-5.
7
Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.脑血管病患者的直接凝血酶抑制剂和因子 Xa 抑制剂。
Expert Rev Neurother. 2012 Feb;12(2):179-89; quiz 190. doi: 10.1586/ern.11.185.
8
[Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)].[心房颤动的栓塞并发症。意大利心房颤动研究（SIFA）的数据]
G Chir. 1995 Mar;16(3):137-9.
9
Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.新型抗凝药物在房颤卒中预防中的应用：当前的临床证据与未来进展。
J Am Coll Cardiol. 2010 Dec 14;56(25):2067-76. doi: 10.1016/j.jacc.2010.09.017.
10
Embolic events in 93 elderly Chinese patients with atrial fibrillation.93例中国老年房颤患者的栓塞事件
Chin Med J (Engl). 2000 Apr;113(4):320-3.

引用本文的文献

1
Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study.合并和未合并充血性心力衰竭的心房颤动患者的临床特征及血栓栓塞风险。CRATF研究结果。
Medicine (Baltimore). 2018 Nov;97(45):e13074. doi: 10.1097/MD.0000000000013074.